Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Filter
  • 1-10 ل  237 نتائج ل ""Cytochrome P-450 CYP2D6""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Toremifene, an Alternative Adjuvant Endocrine Therapy, Is Better Than Tamoxifen in Breast Cancer Patients with CYP2D6*10 Mutant Genotypes.

  • Authors : Li X; Department of Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.; Li Z

Subjects: Tamoxifen*/Tamoxifen*/Tamoxifen*/therapeutic use ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics

  • Source: Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 134-142. Date of Electronic Publication: 2023 Aug 14.Publisher: Korean Cancer Association Country of Publication: Korea (South) NLM ID: 101155137 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Pharmacogenetics of tamoxifen in breast cancer patients of African descent: Lack of data.

  • Authors : Kruger B; Platform for Pharmacogenomics Research and Translation (PREMED), South African Medical Research Council, Cape Town, South Africa.; Pharmacogenomics and Drug Metabolism Research Group, Division of Human Genetics, Department of Pathology and Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Humans ; Female

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Mar; Vol. 17 (3), pp. e13761.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

The Influences of Adherence to Tamoxifen and CYP2D6 Pharmacogenetics on Plasma Concentrations of the Active Metabolite (Z)-Endoxifen in Breast Cancer.

  • Authors : Nardin JM; Clinical Research Department, Erasto Gaertner Hospital, Curitiba, Brazil.; School of Health Science, UniBrasil, Curitiba, Brazil.

Subjects: Assessment of Medication Adherence*; Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

  • Source: Clinical and translational science [Clin Transl Sci] 2020 Mar; Vol. 13 (2), pp. 284-292. Date of Electronic Publication: 2019 Nov 09.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Chinese breast cancer patients with CYP2D6*10 mutant genotypes have a better prognosis with toremifene than with tamoxifen.

  • Authors : Wang H; Department of Science Research and Academic, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning Province, P. R. China.; Ma X

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Tamoxifen*/Tamoxifen*/Tamoxifen*/therapeutic use

  • Source: Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Apr; Vol. 18 (2), pp. e148-e153. Date of Electronic Publication: 2021 Jun 30.Publisher: Blackwell Pub. Asia Country of Publication: Australia NLM ID: 101241430 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Dynamic Effects of CYP2D6 Genetic Variants in a Set of Poor Metaboliser Patients with Infiltrating Ductal Cancer Under Treatment with Tamoxifen.

  • Authors : Ariza Márquez YV; Universidad Nacional de Colombia, Instituto de Biotecnología IBUN, Departamento de Farmacia, Bogota, 111321, Colombia.; Briceño I

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Carcinoma, Ductal/Carcinoma, Ductal/Carcinoma, Ductal/*drug therapy ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics

  • Source: Scientific reports [Sci Rep] 2019 Feb 21; Vol. 9 (1), pp. 2521. Date of Electronic Publication: 2019 Feb 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*genetics ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*metabolism

  • Source: Pharmacology research & perspectives [Pharmacol Res Perspect] 2020 Oct; Vol. 8 (5), pp. e00646.Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States

تفاصيل العنوان

×
Academic Journal

Post-marketing assessment of generic tamoxifen in Brazilian breast cancer patients.

  • Authors : Ximenez JP; Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Brazil.; Lanchote VL

Subjects: Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Drugs, Generic/Drugs, Generic/Drugs, Generic/*administration & dosage ; Tamoxifen/Tamoxifen/Tamoxifen/*administration & dosage

  • Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2020 May; Vol. 126 (5), pp. 432-436. Date of Electronic Publication: 2019 Dec 04.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

تفاصيل العنوان

×
Academic Journal

The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer.

  • Authors : Lammers LA; Department of Hospital Pharmacy, Erasmus MC, University Hospital, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.; Mathijssen RH

Subjects: Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/Cytochrome P-450 CYP2D6/*metabolism

  • Source: British journal of cancer [Br J Cancer] 2010 Sep 07; Vol. 103 (6), pp. 765-71. Date of Electronic Publication: 2010 Aug 10.Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited

تفاصيل العنوان

×
Academic Journal

Relationship between genotypes Sult1a2 and Cyp2d6 and tamoxifen metabolism in breast cancer patients.

  • Authors : Fernández-Santander A; Department of Basic Biomedical Sciences, Faculty of Biomedical Sciences, Cátedra Florencio Tejerina-Universidad Europea de Madrid, Universidad Europea de Madrid, Madrid, Spain. ; Gaibar M

Subjects: Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/Antineoplastic Agents, Hormonal/*metabolism ; Arylsulfotransferase/Arylsulfotransferase/Arylsulfotransferase/*genetics ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*genetics

  • Source: PloS one [PLoS One] 2013 Jul 29; Vol. 8 (7), pp. e70183. Date of Electronic Publication: 2013 Jul 29 (Print Publication: 2013).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: Electronic-Print Cited Medium: Internet

تفاصيل العنوان

×
  • 1-10 ل  237 نتائج ل ""Cytochrome P-450 CYP2D6""